In conclusion, our data demonstrate the ability of CLA and VSL#3 to ameliorate inflammation-induced colorectal cancer through a mechanism involving modulation of mucosal CD4+ T cell polarization and modulation of gene expression. The gene discussed is SELPLG; the disease is colorectal cancer.